About the Corporate Council

The NORD Corporate Council is composed of a select group of leading companies committed to helping people with rare diseases. Members include pharmaceutical, biotech and medical device companies that are developing or marketing therapeutic or diagnostic products, as well as companies that are engaged in other aspects of healthcare for the rare disease/orphan product community such as specialty pharmacies, distributors, contract research organizations, and integrated healthcare systems.

View the list of current members

Corporate Council Membership Benefits

Membership on the Council demonstrates a commitment to the identification, diagnosis, treatment and cure of rare disorders through programs of education, advocacy, research and service. The Council provides unique opportunities for companies to engage with experts in the rare disease community, not only with patient advocacy organizations that constitute NORD’s members, but also with top scientific, clinical and policy experts and leaders in the worldwide rare disease community.

Specific benefits for Pre-Clinical Development, Clinical Development, and Approved Product Members include:

Complimentary participation in Corporate Council Member meetings

Invitations to participate in monthly policy calls

Option to participate in NORD’s Patient Advocacy and Engagement working group

Timely news alerts

Networking opportunities

Special recognition

Special Benefits for Health Care Business Members Include: